Two Banks Downgrade Serologicals Despite Strong Profit Growth, $1.4B Millipore Buyout

Apr 27, 2006

NEW YORK, April 27 (GenomeWeb News) - Two investment banks today have downgraded Serologicals' stock despite string first-quarter profit growth.

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.